Cite

HARVARD Citation

    Van Broekhoven, A. et al. (n.d.). End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial. European heart journal. p. . [Online]. 
  
Back to record